Get the Stockscreener App
3.16
3.66%
-0.12
After Hours:
3.16
Rocket Pharmaceuticals Inc stock is traded at $3.16, with a volume of 1.83M.
It is down -3.66% in the last 24 hours and up +8.59% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$3.28
Open:
$3.26
24h Volume:
1.83M
Relative Volume:
0.45
Market Cap:
$340.98M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.1491
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-3.66%
1M Performance:
+8.59%
6M Performance:
-64.09%
1Y Performance:
-83.32%
1-Day Range:
$3.14
$3.275
1-Week Range:
$3.12
$3.30
52-Week Range:
$2.19
$22.01
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
3.16 | 343.13M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Investors to Connect - ACCESS Newswire
BofA Upgrades Rocket Pharmaceuticals to Buy From Neutral, Adjusts Price Target to $24 From $21 - MarketScreener
Brokerages Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) PT at $16.73 - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Should I trade or invest in Rocket Pharmaceuticals Inc. Equity Warrant2025 Growth vs Value & Community Trade Idea Sharing - Lancaster City Council
Investigation announced for Long-Term Investors in Rocket - openPR.com
Rocket Pharmaceuticals Inc. Breaks Losing Streak — Is the Trend ReversingPrice Action & Daily Price Action Insights - beatles.ru
Analysts Apply Wyckoff Model to Rocket Pharmaceuticals Inc. Equity Warrant StockQuarterly Risk Review & Real-Time Chart Breakout Alerts - beatles.ru
Russell Investments Group Ltd. Trims Stock Position in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Baker BROS. Advisors LP Acquires 1,000,000 Shares of Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Rocket Pharmaceuticals, Inc. $RCKT Shares Bought by MPM Bioimpact LLC - MarketBeat
Is Rocket Pharmaceuticals Inc. Equity Warrant reversing from oversold territoryJuly 2025 Retail & Fast Entry High Yield Tips - Newser
Can machine learning forecast Rocket Pharmaceuticals Inc. recoveryTrade Risk Report & AI Based Buy and Sell Signals - Newser
Nantahala Capital Management LLC Invests $4.20 Million in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Is Rocket Pharmaceuticals Inc. Equity Warrant a candidate for recovery playJuly 2025 Highlights & Consistent Growth Stock Picks - Newser
Is Rocket Pharmaceuticals Inc. Equity Warrant currently under institutional pressureQuarterly Profit Summary & Daily Growth Stock Tips - خودرو بانک
How volatile is Rocket Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک
Nuveen LLC Invests $1.19 Million in Rocket Pharmaceuticals, Inc. $RCKT - MarketBeat
Forecasting Rocket Pharmaceuticals Inc. Equity Warrant price range with options dataTrade Risk Report & Smart Swing Trading Techniques - Newser
Will Rocket Pharmaceuticals Inc. Equity Warrant be affected by tariffsWeekly Profit Summary & Stock Portfolio Risk Control - خودرو بانک
Is Rocket Pharmaceuticals Inc. Equity Warrant forming a double bottomInsider Selling & Weekly Setup with ROI Potential - خودرو بانک
Intraday pattern recognizer results for Rocket Pharmaceuticals Inc.2025 AllTime Highs & Advanced Swing Trade Entry Alerts - Newser
Can Rocket Pharmaceuticals Inc. maintain sales growth2025 Breakouts & Breakdowns & Risk Adjusted Buy/Sell Alerts - خودرو بانک
Smart tools for monitoring Rocket Pharmaceuticals Inc.’s price actionEarnings Miss & Real-Time Volume Trigger Notifications - Newser
Is a relief rally coming for Rocket Pharmaceuticals Inc. Equity Warrant holders2025 Risk Factors & Expert Approved Trade Ideas - Newser
Can trapped investors hope for a rebound in Rocket Pharmaceuticals Inc.2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser
Advanced analytics toolkit walkthrough for Rocket Pharmaceuticals Inc.Weekly Investment Report & Verified Stock Trade Ideas - Newser
How to read the order book for Rocket Pharmaceuticals Inc.Gold Moves & Long-Term Growth Portfolio Plans - Newser
Can a trend reversal in Rocket Pharmaceuticals Inc. lead to recoveryJuly 2025 Short Interest & Risk Controlled Swing Alerts - Newser
Pattern recognition hints at Rocket Pharmaceuticals Inc. upsideJuly 2025 Recap & High Conviction Buy Zone Picks - Newser
When is the best time to exit Rocket Pharmaceuticals Inc.July 2025 Update & Fast Gain Stock Trading Tips - Newser
Custom watchlist performance reports with Rocket Pharmaceuticals Inc. Equity WarrantEarnings Summary Report & Weekly Top Gainers Alerts - Newser
Leading vs lagging indicators on Rocket Pharmaceuticals Inc. Equity Warrant performanceQuarterly Trade Report & Breakout Confirmation Alerts - Newser
Can Rocket Pharmaceuticals Inc. Equity Warrant withstand a market correctionOil Prices & Safe Entry Point Alerts - خودرو بانک
Layoff Tracker: AC Immune To Cut 30% of Workforce - BioSpace
Key resistance and support levels for Rocket Pharmaceuticals Inc.July 2025 Levels & Weekly Momentum Stock Picks - Newser
How cyclical is Rocket Pharmaceuticals Inc.’s revenue streamWeekly Profit Report & AI Driven Stock Price Forecasts - خودرو بانک
Rocket Pharmaceuticals Inc. stock retracement – recovery analysisJuly 2025 Final Week & Growth-Oriented Investment Plans - Newser
The Escalator: Walgreens, Rocket Pharmaceuticals, the CDC and more - Medical Marketing and Media
Published on: 2025-09-04 03:22:27 - Newser
How to monitor Rocket Pharmaceuticals Inc. Equity Warrant with trend dashboardsQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Has Rocket Pharmaceuticals Inc. found a price floor2025 Support & Resistance & High Yield Stock Recommendations - Newser
What to do if you’re stuck in Rocket Pharmaceuticals Inc. Equity Warrant2025 Volatility Report & Short-Term Trading Alerts - Newser
Real time alert setup for Rocket Pharmaceuticals Inc. performanceJuly 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Bull Run: Is Rocket Pharmaceuticals Inc. forming a bullish divergenceJuly 2025 Gainers & Accurate Intraday Trading Signals - خودرو بانک
Rocket Pharmaceuticals Inc. Equity Warrant stock daily chart insightsJuly 2025 Earnings & Long-Term Safe Return Strategies - Newser
Can Rocket Pharmaceuticals Inc. withstand a market correctionJuly 2025 Institutional & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Evaluating Rocket Pharmaceuticals Inc. Equity Warrant with trendline analysisJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Signal Recap: Can Rocket Pharmaceuticals Inc. Equity Warrant weather a recessionJuly 2025 Spike Watch & Consistent Return Investment Signals - خودرو بانک
Will Rocket Pharmaceuticals Inc. continue its uptrendPortfolio Return Summary & Capital Protection Trade Alerts - Newser
Detecting price anomalies in Rocket Pharmaceuticals Inc. Equity Warrant with AI2025 Trading Volume Trends & Safe Entry Zone Tips - Newser
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):